Discover Oncology

OCT 22, 2026 · JOURNAL ARTICLE

Materials-enabled cellular immunotherapy: from manufacturing to in vivo control

Discover Oncology

Cellular immunotherapies have transformed cancer treatment, but broader clinical impact often remains limited by centralized viral-vector-dependent manufacturing, poor performance

OCT 21, 2026 · JOURNAL ARTICLE

The emerging landscape of circular RNAs in lung cancer: biogenesis, function, and clinical translation

Discover Oncology

Circular RNAs (circRNAs), once regarded as aberrant splicing by‑products, have emerged as pivotal non‑coding regulators in lung cancer. This review systematically summarizes the bi

OCT 18, 2026 · JOURNAL ARTICLE

Natural products targeting the metabolic-immune microenvironment to overcome therapeutic resistance in castration-resistant prostate cancer

Discover Oncology

Castration-resistant prostate cancer (CRPC) remains difficult to control because treatment selects adaptive tumour states beyond androgen receptor reactivation. Metabolic rewiring,

OCT 17, 2026 · JOURNAL ARTICLE

Mechanistic integration of genetic alterations, PTM signaling, and tumor microenvironment remodeling in pancreatic ductal adenocarcinoma

Discover Oncology

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, with late diagnosis, rapid progression, considerable therapy resistance, and low overall survival. Gro

OCT 9, 2026 · JOURNAL ARTICLE

Mapping the global research landscape and emerging trends in tumor treating fields for cancer therapy

Discover Oncology

This study aims to map the structural landscape, collaborative networks, and thematic evolution of Tumor Treating Fields (TTFields) research via quantitative bibliometric analysis.

OCT 9, 2026 · JOURNAL ARTICLE

TEFM-mediated regulation of mitochondrial function enhances CAR-T cell activity in ovarian cancer peritoneal metastasis

Discover Oncology

Chimeric antigen receptor (CAR)-T cell therapy in solid tumours is frequently limited by progressive functional impairment and inadequate metabolic fitness within the tumour microe

OCT 7, 2026 · JOURNAL ARTICLE

Advanced-stage psammocarcinoma: two cases and a comprehensive

Discover Oncology

Abstract Psammocarcinoma is a rare variant of serous carcinoma of ovarian or primary peritoneal origin, typically characterized by low-grade nuclear atypia, abundant psammoma body

OCT 7, 2026 · JOURNAL ARTICLE

Advances in research on STEAP3 in malignant tumors

Discover Oncology

Six-Transmembrane Epithelial Antigen of the Prostate 3 (STEAP3) is a six-pass transmembrane protein that plays a pivotal role in regulating intracellular iron and copper metabolism